Published in Nat Biotechnol on December 31, 2006
Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest (2008) 3.33
Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med (2016) 3.04
The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2008) 2.53
The prion protein knockout mouse: a phenotype under challenge. Prion (2007) 1.51
Prions on the move. EMBO Rep (2011) 1.47
Precision editing of large animal genomes. Adv Genet (2012) 1.34
Highly efficient modification of beta-lactoglobulin (BLG) gene via zinc-finger nucleases in cattle. Cell Res (2011) 1.23
Expression of recombinant antibodies. Front Immunol (2013) 1.06
Use of transgenic animals in biotechnology: prospects and problems. Acta Naturae (2013) 0.96
Effect of electrostatics on aggregation of prion protein Sup35 peptide. J Phys Condens Matter (2012) 0.96
Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. Proc Natl Acad Sci U S A (2013) 0.95
Prion protein expression regulates embryonic stem cell pluripotency and differentiation. PLoS One (2011) 0.94
Induced prion protein controls immune-activated retroviruses in the mouse spleen. PLoS One (2007) 0.91
Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease. Toxicol Sci (2010) 0.90
Transcriptomic analysis brings new insight into the biological role of the prion protein during mouse embryogenesis. PLoS One (2011) 0.88
Electroporation advances in large animals. Curr Gene Ther (2009) 0.87
Mutation and selection of prions. PLoS Pathog (2012) 0.87
Prion protein and Shadoo are involved in overlapping embryonic pathways and trophoblastic development. PLoS One (2012) 0.87
A critical analysis of disease-associated DNA polymorphisms in the genes of cattle, goat, sheep, and pig. Mamm Genome (2008) 0.86
Developmental expression of the cellular prion protein (PrP(C) ) in bovine embryos. Mol Reprod Dev (2012) 0.85
Genome engineering in cattle: recent technological advancements. Chromosome Res (2015) 0.85
Healthy goats naturally devoid of prion protein. Vet Res (2012) 0.84
Brain transcriptional stability upon prion protein-encoding gene invalidation in zygotic or adult mouse. BMC Genomics (2010) 0.84
A structural overview of the vertebrate prion proteins. Prion (2007) 0.84
Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells. Transfusion (2011) 0.84
Artificial cloning of domestic animals. Proc Natl Acad Sci U S A (2015) 0.84
To develop with or without the prion protein. Front Cell Dev Biol (2014) 0.83
Evaluating the fitness of human lysozyme transgenic dairy goats: growth and reproductive traits. Transgenic Res (2010) 0.82
A proautophagic antiviral role for the cellular prion protein identified by infection with a herpes simplex virus 1 ICP34.5 mutant. J Virol (2013) 0.81
Characterization of the genomic region containing the Shadow of Prion Protein (SPRN) gene in sheep. BMC Genomics (2007) 0.80
High-level recombinant human lysozyme expressed in milk of transgenic pigs can inhibit the growth of Escherichia coli in the duodenum and influence intestinal morphology of sucking pigs. PLoS One (2014) 0.79
Successes and challenges in phenotype-based lead discovery for prion diseases. J Med Chem (2014) 0.79
Prion protein function and the disturbance of early embryonic development in zebrafish. Prion (2011) 0.79
All quiet on the neuronal front: NMDA receptor inhibition by prion protein. J Cell Biol (2008) 0.78
Factors affecting the development of somatic cell nuclear transfer embryos in Cattle. J Reprod Dev (2014) 0.78
One-step Multiplex Transgenesis via Sleeping Beauty Transposition in Cattle. Sci Rep (2016) 0.78
A specific role for PRND in goat foetal Leydig cells is suggested by prion family gene expression during gonad development in goats and mice. FEBS Open Bio (2016) 0.78
Knockout of Myostatin by Zinc-finger Nuclease in Sheep Fibroblasts and Embryos. Asian-Australas J Anim Sci (2016) 0.77
Is there a risk from not using GE animals? Transgenic Res (2009) 0.77
Pluripotent stem cells and livestock genetic engineering. Transgenic Res (2016) 0.77
The prion protein family: looking outside the central nervous system. Prion (2012) 0.77
A 90-day toxicology study of meat from genetically modified sheep overexpressing TLR4 in Sprague-Dawley rats. PLoS One (2015) 0.77
Germline modification of domestic animals. Anim Reprod (2016) 0.77
The biological function of the cellular prion protein: an update. BMC Biol (2017) 0.76
The Cellular Prion Protein: A Player in Immunological Quiescence. Front Immunol (2015) 0.76
Hematological shift in goat kids naturally devoid of prion protein. Front Cell Dev Biol (2015) 0.76
Comparative analysis of the Shadoo gene between cattle and buffalo reveals significant differences. PLoS One (2012) 0.76
Gene targeting in adult rhesus macaque fibroblasts. BMC Biotechnol (2008) 0.76
Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility. J Biol Chem (2015) 0.75
Generation of exogenous germ cells in the ovaries of sterile NANOS3-null beef cattle. Sci Rep (2016) 0.75
Disparate Modes of Evolution Shaped Modern Prion (PRNP) and Prion-Related Doppel (PRND) Variation in Domestic Cattle. PLoS One (2016) 0.75
Physiological Functions of the Cellular Prion Protein. Front Mol Biosci (2017) 0.75
Efficient PRNP deletion in bovine genome using gene-editing technologies in bovine cells. Prion (2015) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
In vitro generation of infectious scrapie prions. Cell (2005) 6.86
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (2001) 6.20
RNA molecules stimulate prion protein conversion. Nature (2003) 4.06
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60
Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell (1998) 3.59
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (2004) 3.29
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
Distinct molecular phenotypes in bovine prion diseases. EMBO Rep (2004) 2.90
Prion protein is necessary for normal synaptic function. Nature (1994) 2.69
Detection of prions in blood. Nat Med (2005) 2.66
Atypical proteinase K-resistant prion protein (PrPres) observed in an apparently healthy 23-month-old Holstein steer. Jpn J Infect Dis (2003) 2.64
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J (2002) 2.26
Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature (1996) 2.24
Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet (2004) 2.22
Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature (1996) 2.13
Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J (2001) 1.95
Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J (2001) 1.85
Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci U S A (1996) 1.69
Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci (1997) 1.53
Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol (2005) 1.48
Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis (2005) 1.39
Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. J Biol Chem (2000) 1.38
Prion protein and the transmissible spongiform encephalopathy diseases. Neuron (1999) 1.36
Transmission of prions. Proc Natl Acad Sci U S A (2002) 1.36
T-lymphocyte activation and the cellular form of the prion protein. Immunology (1997) 1.13
Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene. Cell Mol Neurobiol (2000) 1.11
Prion protein gene (PRNP) variants and evidence for strong purifying selection in functionally important regions of bovine exon 3. Proc Natl Acad Sci U S A (2004) 1.04
Detection and clinical evolution of scrapie in sheep by 3rd eyelid biopsy. J Vet Intern Med (2006) 0.98
Prion diseases, blood and the immune system: concerns and reality. Haematologica (2000) 0.93
The normal cellular form of prion protein modulates T cell responses. Immunol Lett (2005) 0.92
Detecting mad cow disease. Sci Am (2004) 0.83
Prions and the blood and immune systems. Haematologica (2005) 0.82
In vitro generation of infectious scrapie prions. Cell (2005) 6.86
A twist code determines the onset of osteoblast differentiation. Dev Cell (2004) 5.40
Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci U S A (2003) 3.93
Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem (2006) 2.98
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science (2010) 2.71
Detection of prions in blood. Nat Med (2005) 2.66
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J (2003) 2.34
Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle. Nat Genet (2004) 2.22
Cell-free propagation of prion strains. EMBO J (2008) 2.20
Presymptomatic detection of prions in blood. Science (2006) 2.14
Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol (2002) 2.13
HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog (2010) 2.12
Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell (2008) 2.09
Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol (2006) 2.04
Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature (2002) 2.04
Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem (2002) 2.02
A role for Alström syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet (2006) 1.90
Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog (2008) 1.89
Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry (2006) 1.86
Detection of infectious prions in urine. FEBS Lett (2008) 1.85
De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog (2009) 1.83
Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proc Natl Acad Sci U S A (2002) 1.80
Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat Biotechnol (2002) 1.79
Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett (2005) 1.77
Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med (2014) 1.74
The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci (2005) 1.74
A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc Natl Acad Sci U S A (2009) 1.74
Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5. J Virol (2009) 1.69
Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States. J Vet Diagn Invest (2007) 1.65
Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A (2008) 1.60
Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrol Dial Transplant (2012) 1.59
Which genetic marker for which conservation genetics issue? Electrophoresis (2004) 1.57
Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J Virol (2008) 1.49
Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med (2006) 1.49
Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin Cancer Res (2010) 1.48
Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol (2005) 1.48
Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell (2002) 1.48
Brominated flame retardants, polychlorinated biphenyls, and organochlorine pesticides in captive giant panda (ailuropoda melanoleuca) and red panda (Ailurus fulgens) from China. Environ Sci Technol (2008) 1.48
Leflunomide: friend or foe for systemic lupus erythematosus? Rheumatol Int (2012) 1.45
Platelet-rich plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction. J Surg Res (2013) 1.45
Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods (2010) 1.40
The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta (2006) 1.39
Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity (2005) 1.39
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Clin Cancer Res (2008) 1.35
The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med (2002) 1.35
Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol (2009) 1.34
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem (2003) 1.34
Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci (2010) 1.33
Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie. Emerg Infect Dis (2009) 1.33
Structural study of silver(I) sulfonate complexes with pyrazine derivatives. Inorg Chem (2007) 1.33
Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol (2002) 1.33
Aurora A, meiosis and mitosis. Biol Cell (2004) 1.31
Prion protein glycosylation is not required for strain-specific neurotropism. J Virol (2009) 1.31
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein. Antiviral Res (2008) 1.30
In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms. PLoS Genet (2009) 1.29
pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol (2004) 1.27
Amyloid formation modulates the biological activity of a bacterial protein. J Biol Chem (2005) 1.27
Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin Cell Dev Biol (2011) 1.25
NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling. Cancer Cell (2010) 1.22
Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. Microvasc Res (2008) 1.22
Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000. J Immunol Methods (2004) 1.19
The controversial protein-only hypothesis of prion propagation. Nat Med (2004) 1.18
Unidirectionally progressive resection of lower right lung cancer under video-assisted thoracoscopy. J Thorac Dis (2013) 1.18
Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol (2009) 1.17
Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog (2011) 1.17
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A (2007) 1.15
Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol (2010) 1.15
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas. J Med Chem (2005) 1.14
Perturbation of endoplasmic reticulum homeostasis facilitates prion replication. J Biol Chem (2007) 1.13
Generation of a new form of human PrP(Sc) in vitro by interspecies transmission from cervid prions. J Biol Chem (2011) 1.12
Prion protein misfolding affects calcium homeostasis and sensitizes cells to endoplasmic reticulum stress. PLoS One (2010) 1.11
A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell development. Proc Natl Acad Sci U S A (2007) 1.11
Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J (2002) 1.11
Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev (2010) 1.11
Protein misfolding cyclic amplification of infectious prions. Nat Protoc (2012) 1.10
New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation. Antimicrob Agents Chemother (2009) 1.10
Is loss of function of the prion protein the cause of prion disorders? Trends Mol Med (2003) 1.10
Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog (2013) 1.10
Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2. Clin Cancer Res (2005) 1.09
High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol (2012) 1.09
Theory of activated-rate processes under shear with application to shear-induced aggregation of colloids. Phys Rev E Stat Nonlin Soft Matter Phys (2009) 1.08
Cellular factors implicated in prion replication. FEBS Lett (2010) 1.07
Treatment of thoracolumbar vertebrate fracture by transpedicular morselized bone grafting in vertebrae for spinal fusion and pedicle screw fixation. J Huazhong Univ Sci Technolog Med Sci (2008) 1.07
Direct generation of induced pluripotent stem cells from human nonmobilized blood. Stem Cells Dev (2010) 1.06
Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results. World J Gastroenterol (2008) 1.06
Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am J Pathol (2004) 1.04